4.7 Article Proceedings Paper

Direct Mutagenesis of Thousands of Genomic Targets Using Microarray-Derived Oligonucleotides

期刊

ACS SYNTHETIC BIOLOGY
卷 4, 期 1, 页码 17-22

出版社

AMER CHEMICAL SOC
DOI: 10.1021/sb5001565

关键词

genome engineering; MAGE; metabolic engineering; microarray; library synthesis

资金

  1. National Institutes of Health Director's Early Independence Award [1DP5OD009172-01]
  2. Department of Energy (DOE)
  3. National Science Foundation (NSF) [SA5283-11210]
  4. Novo Nordisk Foundation
  5. European Union Seventh Framework Programme [FP7-KBBE-2013-7-single-stage, 613745]
  6. Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish

向作者/读者索取更多资源

Multiplex Automated Genome Engineering (MAGE) allows simultaneous mutagenesis of multiple target sites in bacterial genomes using short oligonucleotides. However, large-scale mutagenesis requires hundreds to thousands of unique oligos, which are costly to synthesize and impossible to scale-up by traditional phosphoramidite column-based approaches. Here, we describe a novel method to amplify oligos from microarray chips for direct use in MAGE to perturb thousands of genomic sites simultaneously. We demonstrated the feasibility of large-scale mutagenesis by inserting T7 promoters upstream of 2585 operons in E. coli using this method, which we call Microarray-Oligonucleotide (MO)-MAGE. The resulting mutant library was characterized by high-throughput sequencing to show that all attempted insertions were estimated to have occurred at an average frequency of 0.02% per locus with 0.4 average insertions per cell. MO-MAGE enables cost-effective large-scale targeted genome engineering that should be useful for a variety of applications in synthetic biology and metabolic engineering.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据